Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Breast Cancer

Free Subscription 17.08.2020 1 Am J Surg 3 Ann Surg Oncol 6 BMC Cancer 2 Breast Cancer 4 Breast Cancer Res 14 Breast Cancer Res Treat 3 Breast J 3 Cancer 1 Cancer Chemother Pharmacol 2 Cancer Epidemiol Biomarkers Prev 3 Cancer Lett 5 Clin Breast Cancer 1 Curr Treat Options Oncol 1 Eur J Surg Oncol 3 Gene 3 J Natl Cancer Inst 1 J Surg Oncol 4 Lancet 2 Lancet Oncol 1 Mod Pathol 1 Nature 2 Oncogene 3 PLoS One 1 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. HABRAWI Z, Melkus MW, Khan S, Henderson J, et al
   Cryoablation: A promising non-operative therapy for low-risk breast cancer.
   Am J Surg. 2020 Aug 1. pii: S0002-9610(20)30482.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. PILTIN MA, Hoskin TL, Day CN, Davis J Jr, et al
   Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer.
   Ann Surg Oncol. 2020 Aug 10. pii: 10.1245/s10434-020-08900.
   PubMed         Abstract available
   
   
3. HUANG TW, Su CM, Tam KW
   Correction to: Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.
   Ann Surg Oncol. 2020 Aug 10. pii: 10.1245/s10434-020-08987.
   PubMed         Abstract available
   
   
4. CROWN A, Muhsen S, Zabor EC, Sevilimedu V, et al
   Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
   Ann Surg Oncol. 2020 Aug 7. pii: 10.1245/s10434-020-08883.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. WANG B, Lu Z, Huang Y, Li R, et al
   Does hypothyroidism increase the risk of breast cancer: evidence from a meta-analysis.
   BMC Cancer. 2020;20:733.
   PubMed         Abstract available
   
   
6. MUZZATTI B, Bomben F, Flaiban C, Piccinin M, et al
   Quality of life and psychological distress during cancer: a prospective observational study involving young breast cancer female patients.
   BMC Cancer. 2020;20:758.
   PubMed         Abstract available
   
   
7. DU X, Todorov P, Isachenko E, Rahimi G, et al
   Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation.
   BMC Cancer. 2020;20:753.
   PubMed         Abstract available
   
   
8. MAAYAH ZH, Takahara S, Alam AS, Ferdaoussi M, et al
   Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling.
   BMC Cancer. 2020;20:751.
   PubMed         Abstract available
   
   
9. SHAO C, Yu Z, Xiao J, Liu L, et al
   Prognosis of pregnancy-associated breast cancer: a meta-analysis.
   BMC Cancer. 2020;20:746.
   PubMed         Abstract available
   
   
10. GOVINDAN S, Siraganahalli Eswaraiah M, Basavaraj C, Adinarayan M, et al
    Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients.
    BMC Cancer. 2020;20:745.
    PubMed         Abstract available
    
    

    
    Breast Cancer

11. ZHONG W, Yang Y, Zhang A, Lin W, et al
    Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer.
    Breast Cancer. 2020 Aug 11. pii: 10.1007/s12282-020-01142.
    PubMed         Abstract available
    
    
12. ISHIDA K, Ohnuki K, Usami S, Komatsu H, et al
    A survey on the current status of clinical resources for diagnosis and treatment of breast cancer in rural hospitals of the Tohoku region in Japan.
    Breast Cancer. 2020 Aug 13. pii: 10.1007/s12282-020-01144.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

13. DIAZ-SANTANA MV, O'Brien KM, D'Aloisio AA, Regalado G, et al
    Perinatal and postnatal exposures and risk of young-onset breast cancer.
    Breast Cancer Res. 2020;22:88.
    PubMed         Abstract available
    
    
14. NANOU A, Zeune LL, Bidard FC, Pierga JY, et al
    HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer.
    Breast Cancer Res. 2020;22:86.
    PubMed         Abstract available
    
    
15. PORTMAN N, Milioli HH, Alexandrou S, Coulson R, et al
    MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer.
    Breast Cancer Res. 2020;22:87.
    PubMed         Abstract available
    
    
16. LI L, Lin L, Veeraraghavan J, Hu Y, et al
    Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance.
    Breast Cancer Res. 2020;22:84.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

17. D'HONDT C, Vanhoeij M, Van Moer E, Segers I, et al
    Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
    Breast Cancer Res Treat. 2020 Aug 13. pii: 10.1007/s10549-020-05858.
    PubMed         Abstract available
    
    
18. WILLIAMS CB, Nebhan CA, Yang J, Starnes LS, et al
    Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy.
    Breast Cancer Res Treat. 2020 Aug 7. pii: 10.1007/s10549-020-05846.
    PubMed         Abstract available
    
    
19. SCHETTINI F, Sobhani N, Ianza A, Triulzi T, et al
    Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study.
    Breast Cancer Res Treat. 2020 Aug 7. pii: 10.1007/s10549-020-05856.
    PubMed         Abstract available
    
    
20. KANJANAPAN Y, Lok SW, Gibbs P, De Boer R, et al
    Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Aug 10. pii: 10.1007/s10549-020-05825.
    PubMed         Abstract available
    
    
21. CADY B, Fulton JP
    57% decline in Rhode Island invasive breast cancer mortality between 1987 and 2017: mammography predominates in preventing mortality.
    Breast Cancer Res Treat. 2020 Aug 10. pii: 10.1007/s10549-020-05834.
    PubMed         Abstract available
    
    
22. ZHANG Y, Dian L, Wei X, Huang J, et al
    Physicians' attitudes towards reproduction in young patients with early breast cancer in China.
    Breast Cancer Res Treat. 2020 Aug 10. pii: 10.1007/s10549-020-05854.
    PubMed         Abstract available
    
    
23. BI Z, Chen P, Liu YB, Zhao T, et al
    Efficacy and safety analysis of paclitaxel, docetaxel and liposomal paclitaxel after neoadjuvant therapy in breast cancer.
    Breast Cancer Res Treat. 2020 Aug 10. pii: 10.1007/s10549-020-05851.
    PubMed         Abstract available
    
    
24. SOKOLENKO AP, Sokolova TN, Ni VI, Preobrazhenskaya EV, et al
    Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
    Breast Cancer Res Treat. 2020 Aug 9. pii: 10.1007/s10549-020-05827.
    PubMed         Abstract available
    
    
25. CRYSTAL JS, Rand J, Johnson J, Kim S, et al
    Adjuvant endocrine therapy is associated with improved overall survival in elderly hormone receptor-positive breast cancer patients.
    Breast Cancer Res Treat. 2020 Aug 9. pii: 10.1007/s10549-020-05823.
    PubMed         Abstract available
    
    
26. CHEN J, Lai YH, Ooi S, Song Y, et al
    BTB domain-containing 7 predicts low recurrence and suppresses tumor progression by deactivating Notch1 signaling in breast cancer.
    Breast Cancer Res Treat. 2020 Aug 8. pii: 10.1007/s10549-020-05857.
    PubMed         Abstract available
    
    
27. PAPAUTSKY EL, Hamlish T
    Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic.
    Breast Cancer Res Treat. 2020 Aug 9. pii: 10.1007/s10549-020-05828.
    PubMed         Abstract available
    
    
28. RUGO HS, Dieras V, Cortes J, Patt D, et al
    Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2-metastatic breast cancer receiving single-agent chemotherapy-a comparison with MONARCH 1.
    Breast Cancer Res Treat. 2020 Aug 12. pii: 10.1007/s10549-020-05838.
    PubMed         Abstract available
    
    
29. BARTLETT DB, Broadwater G, White HK, Shelby R, et al
    Factors associated with falls in older women with breast cancer: the use of a brief geriatric screening tool in clinic.
    Breast Cancer Res Treat. 2020 Aug 13. pii: 10.1007/s10549-020-05862.
    PubMed         Abstract available
    
    
30. TREVINO KM, Iyengar N, Li Q, Mao JJ, et al
    Receipt of psychological counseling and integrative medicine services among breast cancer survivors with anxiety.
    Breast Cancer Res Treat. 2020 Aug 9. pii: 10.1007/s10549-020-05859.
    PubMed         Abstract available
    
    

    
    Breast J

31. MACHIELS M, Weytjens R, Erven K, Westerhoff JM, et al
    Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.13986.
    PubMed         Abstract available
    
    
32. CHAHUAN B, Soza-Ried C, Farina A, Calvo FA, et al
    Management plan for breast cancer during the COVID-19 pandemic. A single-institution alternative to treat early breast cancer patients in a short time.
    Breast J. 2020 Aug 6. doi: 10.1111/tbj.13943.
    PubMed        
    
    
33. MASOOD S
    Breast cancer risk assessment and management.
    Breast J. 2020 Aug 11. doi: 10.1111/tbj.14013.
    PubMed        
    
    

    
    Cancer

34. VYSOTSKAIA V, Kaseniit KE, Bucheit L, Ready K, et al
    Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Cancer. 2020;126:549-558.
    PubMed         Abstract available
    
    
35. KIM EY, Chang Y, Ahn J, Yun JS, et al
    Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.
    Cancer. 2020 Aug 7. doi: 10.1002/cncr.33138.
    PubMed         Abstract available
    
    
36. CHRISTGEN M, Gluz O, Harbeck N, Kates RE, et al
    Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
    Cancer. 2020 Aug 11. doi: 10.1002/cncr.33104.
    PubMed         Abstract available
    
    

    
    Cancer Chemother Pharmacol

37. TONRA JR, Lloyd GK, Mohanlal R, Huang L, et al
    Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies.
    Cancer Chemother Pharmacol. 2020;85:461-468.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

38. HWANG KT, Han KD, Oh S, Koo BK, et al
    Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 6. pii: 1055-9965.EPI-20-0300.
    PubMed         Abstract available
    
    
39. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    PubMed         Abstract available
    
    

    
    Cancer Lett

40. SHEN L, Kang L, Wang D, Xun J, et al
    Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation.
    Cancer Lett. 2020;472:40-49.
    PubMed         Abstract available
    
    
41. TEOH ST, Ogrodzinski MP, Lunt SY
    UDP-glucose 6-dehydrogenase knockout impairs migration and decreases in vivo metastatic ability of breast cancer cells.
    Cancer Lett. 2020 Aug 5. pii: S0304-3835(20)30388.
    PubMed         Abstract available
    
    
42. REN J, Wang Y, Ware T, Iaria J, et al
    Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
    Cancer Lett. 2020 Aug 5. pii: S0304-3835(20)30398.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

43. STASTNY I, Zubor P, Kajo K, Kubatka P, et al
    Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer.
    Clin Breast Cancer. 2020 May 16. pii: S1526-8209(20)30111.
    PubMed         Abstract available
    
    
44. PARIS I, Di Giorgio D, Carbognin L, Corrado G, et al
    Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach.
    Clin Breast Cancer. 2020 Jul 20. pii: S1526-8209(20)30173.
    PubMed         Abstract available
    
    
45. GOEL AK, Zamre V, Chaudhary P, Sharma G, et al
    High Oncotype Recurrence Score, Hereditary Cancer Syndromes, and Referral for Genetic Testing.
    Clin Breast Cancer. 2020;20:e196-e197.
    PubMed        
    
    
46. CASASANTA N, Amdur R, Kaltman R
    Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing.
    Clin Breast Cancer. 2020;20:e198-e199.
    PubMed        
    
    
47. SHI J, Shao X, Guo X, Fang W, et al
    Dietary Habits and Breast Cancer Risk: A Hospital-Based Case-Control Study in Chinese Women.
    Clin Breast Cancer. 2020 Feb 27. pii: S1526-8209(20)30042.
    PubMed         Abstract available
    
    

    
    Curr Treat Options Oncol

48. MARTI JLG, Hyder T, Nasrazadani A, Brufsky AM, et al
    The Evolving Landscape of HER2-Directed Breast Cancer Therapy.
    Curr Treat Options Oncol. 2020;21:82.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

49. VAN BOMMEL ACM, de Ligt KM, Schreuder K, Maduro JH, et al
    The added value of immediate breast reconstruction to health-related quality of life of breast cancer patients.
    Eur J Surg Oncol. 2020 Jun 11. pii: S0748-7983(20)30530.
    PubMed         Abstract available
    
    

    
    Gene

50. WANG J, Yang Z, Zhang C, Ouyang J, et al
    A Four-Gene Signature in the Tumor Microenvironment That Significantly Associates with the Prognosis of Patients with Breast Cancer.
    Gene. 2020 Aug 10:145049. doi: 10.1016/j.gene.2020.145049.
    PubMed        
    
    
51. DOMINGUEZ-DE-LA-CRUZ E, de Lourdes Munoz M, Perez-Munoz A, Garcia-Hernandez N, et al
    Reduced mitochondrial DNA copy number is associated with the haplogroup, and some clinical features of breast cancer in Mexican patients.
    Gene. 2020 Aug 9:145047. doi: 10.1016/j.gene.2020.145047.
    PubMed         Abstract available
    
    
52. RAJAGOPAL T, Seshachalam A, Akshaya RL, Kumar Rathnam K, et al
    Association of HOTAIR (rs920778 and rs1899663) and NME1 (rs16949649 and rs2302254) gene polymorphisms with breast cancer risk in India.
    Gene. 2020 Aug 8:145033. doi: 10.1016/j.gene.2020.145033.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

53. MAGBANUA MJM, Hendrix LH, Hyslop T, Barry WT, et al
    Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy.
    J Natl Cancer Inst. 2020 Aug 8. pii: 5889954. doi: 10.1093.
    PubMed         Abstract available
    
    
54. CHIARELLI AM, Blackmore KM, Muradali D, Done SJ, et al
    Performance Measures of Magnetic Resonance Imaging Plus Mammography in the High Risk Ontario Breast Screening Program.
    J Natl Cancer Inst. 2020;112:136-144.
    PubMed         Abstract available
    
    
55. MAGUIRE S, Perraki E, Tomczyk K, Jones ME, et al
    Common susceptibility loci for male breast cancer.
    J Natl Cancer Inst. 2020 Aug 12. pii: 5885091. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

56. SPAUTZ CC, Schunemann Junior E, Budel LR, Cavalcanti TCS, et al
    Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging.
    J Surg Oncol. 2020;122:164-169.
    PubMed         Abstract available
    
    

    
    Lancet

57. MORIS D, Kontos M
    Recurrence of breast cancer after anaesthesia.
    Lancet. 2020;396:376-377.
    PubMed        
    
    
58. SESSLER DI
    Recurrence of breast cancer after anaesthesia - Author's reply.
    Lancet. 2020;396:377-378.
    PubMed        
    
    
59. ISHIKAWA M, Sakamoto A, Ma D
    Recurrence of breast cancer after anaesthesia.
    Lancet. 2020;396:375-376.
    PubMed        
    
    
60. NIELSEN KC, Melton MS, Gebhard RE, Greengrass RA, et al
    Recurrence of breast cancer after anaesthesia.
    Lancet. 2020;396:376.
    PubMed        
    
    

    
    Lancet Oncol

61. MARINGE C, Spicer J, Morris M, Purushotham A, et al
    The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Lancet Oncol. 2020 Jul 20. pii: S1470-2045(20)30388.
    PubMed         Abstract available
    
    
62. DOMCHEK SM, Postel-Vinay S, Im SA, Park YH, et al
    Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study.
    Lancet Oncol. 2020 Aug 6. pii: S1470-2045(20)30324.
    PubMed         Abstract available
    
    

    
    Mod Pathol

63. ALDREES R, Gao X, Zhang K, Siegal GP, et al
    Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution.
    Mod Pathol. 2020 Aug 10. pii: 10.1038/s41379-020-00650.
    PubMed         Abstract available
    
    

    
    Nature

64. YANG L, Liu Q, Zhang X, Liu X, et al
    DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25.
    Nature. 2020;583:133-138.
    PubMed         Abstract available
    
    

    
    Oncogene

65. LIU H, Gruber CW, Alewood PF, Moller A, et al
    The oxytocin receptor signalling system and breast cancer: a critical review.
    Oncogene. 2020 Aug 11. pii: 10.1038/s41388-020-01415.
    PubMed         Abstract available
    
    
66. LIN B, Li Y, Wang T, Qiu Y, et al
    CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
    Oncogene. 2020 Aug 10. pii: 10.1038/s41388-020-01412.
    PubMed         Abstract available
    
    

    
    PLoS One

67. DRUCKER A, Teh EM, Kostyleva R, Rayson D, et al
    Comparative performance of different methods for circulating tumor cell enrichment in metastatic breast cancer patients.
    PLoS One. 2020;15:e0237308.
    PubMed         Abstract available
    
    
68. VIJAYASARVESWARI V, Andrew AM, Jusoh M, Sabapathy T, et al
    Multi-stage feature selection (MSFS) algorithm for UWB-based early breast cancer size prediction.
    PLoS One. 2020;15:e0229367.
    PubMed         Abstract available
    
    
69. ELSHARKAWY M, Vestring T, Raatschen HJ
    A ten-year, single-center experience: Concordance between breast core needle biopsy/vacuum-assisted biopsy and postoperative histopathology in B3 and B5a cases.
    PLoS One. 2020;15:e0233574.
    PubMed         Abstract available
    
    

    
    Radiology

70. SLANETZ PJ
    Digital Breast Tomosynthesis Screening for Breast Cancer: It Is Cost-Effective!
    Radiology. 2020 Aug 4:202779. doi: 10.1148/radiol.2020202779.
    PubMed        
    
    

    
    Radiother Oncol

71. OLIVOTTO IA, Link E, Phillips C, Whelan TJ, et al
    International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
    Radiother Oncol. 2020;142:180-185.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: